title: Hormonal treatment duration in elderly patients: an open question.
authors.forename: Diana
authors.initials: D
authors.lastname: Crivellari
authors.forename: Aron
authors.initials: A
authors.lastname: Goldhirsch
authors.forename: Alan
authors.initials: A
authors.lastname: Coates
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018579:Patient Selection; D012306:Risk; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D013923:Thromboembolism / Q000139:chemically induced* / Q000453:epidemiology
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen